The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
28277660 |
30 |
Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid Scaffold. |
Shanghai Institute Of Materia Medica |
28076827 |
27 |
New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activity. |
Universit£ |
27918994 |
18 |
Importance of 5/6-aryl substitution on the pharmacological profile of 4'-((2-propyl-1H-benzo[d]imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid derived PPAR¿ agonists. |
University Of Innsbruck |
28117121 |
9 |
Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPAR¿ and SUR agonists. |
Al-Azhar University |
27876250 |
60 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH |
Jagiellonian University Medical College |
27560282 |
11 |
Evaluation of selected 3D virtual screening tools for the prospective identification of peroxisome proliferator-activated receptor (PPAR)¿ partial agonists. |
University Of Innsbruck |
27569195 |
16 |
New telmisartan-derived PPAR¿ agonists: Impact of the 3D-binding mode on the pharmacological profile. |
Universit£T Innsbruck |
27815118 |
112 |
Discovery of phenoxyindazoles and phenylthioindazoles as ROR¿ inverse agonists. |
Galderma R & D |
27591006 |
24 |
Discovery of N-(1-(3-(4-phenoxyphenyl)-1,2,4-oxadiazol-5-yl)ethyl)acetamides as novel acetyl-CoA carboxylase 2 (ACC2) inhibitors with peroxisome proliferator-activated receptora/d (PPARa/d) dual agonistic activity. |
The University Of Tokyo |
27326332 |
66 |
Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARa Selective Agonist. |
Bristol-Myers Squibb |
26988801 |
55 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents. |
Jagiellonian University Medical College |
26819660 |
82 |
SAR Exploration Guided by LE and Fsp(3): Discovery of a Selective and Orally Efficacious ROR¿ Inhibitor. |
Central Pharmaceutical Research Institute |
27020685 |
4 |
Synthetic approaches to the 2014 new drugs. |
Pfizer |
26731300 |
3 |
Amorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria. |
Max Planck Institute For Molecular Genetics |
26595749 |
77 |
N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor¿ Modulators. |
Goethe-University Frankfurt |
26708109 |
10 |
Design and synthesis of novel Y-shaped barbituric acid derivatives as PPAR¿ activators. |
National Institute Of Pharmaceutical Education And Research (Niper) |
26707398 |
2 |
Characterization of isobutylhydroxyamides with NGF-potentiating activity from Zanthoxylum bungeanum. |
Northwest A & F University |
26258602 |
39 |
Discovery of Selective Small Molecule Inhibitors of Monoacylglycerol Acyltransferase 3. |
Pfizer |
26226490 |
23 |
Novel Oxazolidinone-Based Peroxisome Proliferator Activated Receptor Agonists: Molecular Modeling, Synthesis, and Biological Evaluation. |
Iqm-Csic |
26048793 |
91 |
Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists. |
Genentech |
25982078 |
13 |
Design, synthesis, and biological evaluation of a series of alkoxy-3-indolylacetic acids as peroxisome proliferator-activated receptor¿/d agonists. |
Sookmyung Women'S University |
25583100 |
107 |
Anthranilic acid derivatives as nuclear receptor modulators--development of novel PPAR selective and dual PPAR/FXR ligands. |
Goethe-University Frankfurt |
25262940 |
3 |
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPAR¿ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes. |
University Of Copenhagen |
25938459 |
1 |
Amorfrutins Are Natural PPAR¿ Agonists with Potent Anti-inflammatory Properties. |
Max Planck Institute For Molecular Genetics |
25890697 |
6 |
Thiazolidine-2,4-dione derivatives: programmed chemical weapons for key protein targets of various pathological conditions. |
Punjabi University |
25734377 |
11 |
Peroxisome Proliferator-Activated Receptor¿ (PPAR¿) and Ligand Choreography: Newcomers Take the Stage. |
Universitat Rovira I Virgili (Urv) |
25815144 |
17 |
Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist. |
Daiichi Sankyo |
25978962 |
8 |
Separation and peroxisome proliferator-activated receptor-¿ agonist activity evaluation of synthetic racemic bavachinin enantiomers. |
Shanghai University Of Traditional Chinese Medicine |
25686852 |
191 |
Synthesis and biological evaluation of novel pyrrolidine acid analogs as potent dual PPARa/¿ agonists. |
Bristol-Myers Squibb Research And Development (R & D) |
25575659 |
124 |
SAR-studies of¿-secretase modulators with PPAR¿-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's disease. |
Goethe-University Frankfurt |
25497132 |
34 |
Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptora/¿ ligand LT175. |
Universit£ |
25037914 |
76 |
Identification of pirinixic acid derivatives bearing a 2-aminothiazole moiety combines dual PPARa/¿ activation and dual 5-LO/mPGES-1 inhibition. |
Goethe-University Frankfurt |
25022880 |
24 |
Molecular determinants for improved activity at PPARa: structure-activity relationship of pirinixic acid derivatives, docking study and site-directed mutagenesis of PPARa. |
Goethe-University Frankfurt |
25017035 |
20 |
Molecular dynamics study-guided identification of cyclic amine structures as novel hydrophobic tail components of hPPAR¿ agonists. |
Okayama University |
24881566 |
140 |
Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120). |
Glaxosmithkline |
25491112 |
19 |
Biological evaluation and structural insights for design of subtype-selective peroxisome proliferator activated receptor-a (PPAR-a) agonists. |
National Institute Of Pharmaceutical Education And Research (Niper) |
25462281 |
17 |
Structural development studies of PPARs ligands based on tyrosine scaffold. |
Universit£&Quot;G. D'Annunzio&Quot |
25333853 |
6 |
Polyyne hybrid compounds from Notopterygium incisum with peroxisome proliferator-activated receptor gamma agonistic effects. |
Karl-Franzens-University Graz |
25305688 |
41 |
Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORß and ROR¿t. |
Phenex Pharmaceuticals |
25255039 |
45 |
Extending the structure-activity relationship of anthranilic acid derivatives as farnesoid X receptor modulators: development of a highly potent partial farnesoid X receptor agonist. |
Goethe-University Frankfurt |
24821375 |
5 |
The dipeptide H-Trp-Glu-OH (WE) shows agonistic activity to peroxisome proliferator-activated protein-a and reduces hepatic lipid accumulation in lipid-loaded H4IIE cells. |
Korea University |
24745969 |
36 |
Identification of the first potent, selective and bioavailable PPARa antagonist. |
Inception Sciences |
9836620 |
94 |
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents. |
Glaxo Wellcome Research And Development |
23294830 |
88 |
Discovery of INT131: a selective PPAR¿ modulator that enhances insulin sensitivity. |
Amgen |
23286787 |
18 |
Structural characterization of amorfrutins bound to the peroxisome proliferator-activated receptor¿. |
Helmholtz Centre For Infection Research |
23265844 |
18 |
The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists. |
The University Of Sydney |
23265881 |
49 |
Design, synthesis, and evaluation of imidazo[4,5-c]pyridin-4-one derivatives with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-¿. |
Pfizer |
24900572 |
54 |
Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes. |
Pfizer |
23171045 |
38 |
New 2-(aryloxy)-3-phenylpropanoic acids as peroxisome proliferator-activated receptora/¿ dual agonists able to upregulate mitochondrial carnitine shuttle system gene expression. |
Universit� |
17533125 |
36 |
Co-crystal structure guided array synthesis of PPARgamma inverse agonists. |
Glaxosmithkline |
17482722 |
22 |
QSAR analysis of PPAR-gamma agonists as anti-diabetic agents. |
Central Drug Research Institute |
21414782 |
178 |
Phenoxyacetic acids as PPARd partial agonists: synthesis, optimization, and in vivo efficacy. |
Glaxosmithkline |
20444603 |
2 |
Flexible ligand recognition of peroxisome proliferator-activated receptor-gamma (PPARgamma). |
Rikkyo University |
20128594 |
51 |
Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonist. |
Glaxosmithkline |
23186307 |
2 |
PPAR¿ agonist from Chromolaena odorata. |
Hebei Medical University |
23102891 |
34 |
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs. |
Universit£ |
23084275 |
48 |
Design, synthesis and evaluation of novel zwitterionic compounds as PPARa/¿ dual agonists (1). |
Daiichi Sankyo |
22081932 |
32 |
Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activity. |
Istituto Tumori&Quot;Giovanni Paolo Ii&Quot |
23130964 |
25 |
Design and synthesis of dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptors. |
Zafes/Liff/Osf Goethe-University Frankfurt |
22934537 |
4 |
Plakilactones from the marine sponge Plakinastrella mamillaris. Discovery of a new class of marine ligands of peroxisome proliferator-activated receptor¿. |
Universit£ |
22424975 |
4 |
Sesquiterpene lactones from Tithonia diversifolia act as peroxisome proliferator-activated receptor agonists. |
National Kaohsiung Normal University |
23031596 |
21 |
Diarylheptanoid glycosides from Tacca plantaginea and their effects on NF-¿B activation and PPAR transcriptional activity. |
Chungnam National University |
23022278 |
14 |
Design, synthesis and in vitro evaluation of a series ofa-substituted phenylpropanoic acid PPAR¿ agonists to further investigate the stereochemistry-activity relationship. |
Okayama University |
21800856 |
50 |
Lignan derivatives from Krameria lappacea roots inhibit acute inflammation in vivo and pro-inflammatory mediators in vitro. |
University Of Innsbruck |
22324546 |
55 |
Synthesis and evaluation of sulfonylnitrophenylthiazoles (SNPTs) as thyroid hormone receptor-coactivator interaction inhibitors. |
Institut Pasteur Korea |
22260081 |
12 |
Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators. |
Universit£ |
22582973 |
21 |
Integrated virtual screening for the identification of novel and selective peroxisome proliferator-activated receptor (PPAR) scaffolds. |
Trinity College |
22727448 |
16 |
Synthesis and biological evaluation of novel (-)-Cercosporamide derivatives as potent selective PPAR¿ modulators. |
Daiichi Sankyo |
22564380 |
624 |
Activity landscape modeling of PPAR ligands with dual-activity difference maps. |
Universidad Nacional Aut£Noma De M£Xico |
22534184 |
87 |
Discovery, design and synthesis of Y-shaped peroxisome proliferator-activated receptord agonists as potent anti-obesity agents in vivo. |
Seoul National University |
22424300 |
3 |
Polyhydroxylated macrolides from Seimatosporium discosioides and their effects on the activation of peroxisome proliferator-activated receptor gamma. |
Korea University |
22579420 |
45 |
Total synthesis and dual PPARa/¿ agonist effects of amorphastilbol and its synthetic derivatives. |
Korea Institute Of Science And Technology |
22503460 |
37 |
Structure-activity relationships and key structural feature of pyridyloxybenzene-acylsulfonamides as new, potent, and selective peroxisome proliferator-activated receptor (PPAR)¿ Agonists. |
Takeda Pharmaceutical |
22381047 |
30 |
Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii. |
Chungnam National University |
21218783 |
117 |
Identification of diaryl ether-based ligands for estrogen-related receptora as potential antidiabetic agents. |
Johnson & Johnson Pharmaceutical Research And Development |
21128600 |
16 |
Design, synthesis, and structural analysis of phenylpropanoic acid-type PPAR¿-selective agonists: discovery of reversed stereochemistry-activity relationship. |
Okayama University |
20527969 |
27 |
Design, synthesis, and structure-activity relationship studies of novel 2,4,6-trisubstituted-5-pyrimidinecarboxylic acids as peroxisome proliferator-activated receptor gamma (PPARgamma) partial agonists with comparable antidiabetic efficacy to rosiglitazone. |
Kyorin Pharmaceutical |
20299214 |
20 |
(S)-3-(4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-(piperazin-1-yl) propanoic acid compounds: synthesis and biological evaluation of dual PPARalpha/gamma agonists. |
Institute Of Pharmacology And Toxicology |
20219371 |
22 |
Discovery of a novel selective PPARgamma modulator from (-)-Cercosporamide derivatives. |
Daiichi Sankyo |
19879669 |
3 |
Identification of (beta-carboxyethyl)-rhodanine derivatives exhibiting peroxisome proliferator-activated receptor gamma activity. |
Sookmyung Women'S University |
20138762 |
5 |
Acidic elements in histamine H(3) receptor antagonists. |
Johann Wolfgang Goethe University |
19574056 |
25 |
Discovery of novel dual functional agent as PPARgamma agonist and 11beta-HSD1 inhibitor for the treatment of diabetes. |
Chinese Academy Of Sciences |
18329752 |
14 |
Tryptophan-containing dipeptide derivatives as potent PPARgamma antagonists: design, synthesis, biological evaluation, and molecular modeling. |
Graduate School Of The Chinese Academy Of Sciences |
18976908 |
18 |
Modulation of PPAR receptor subtype selectivity of the ligands: aliphatic chain vs aromatic ring as a spacer between pharmacophore and the lipophilic moiety. |
Zydus Research Centre |
18826205 |
61 |
Design, synthesis, and biological evaluation of novel constrained meta-substituted phenyl propanoic acids as peroxisome proliferator-activated receptor alpha and gamma dual agonists. |
Seoul National University |
18511276 |
86 |
Design, synthesis, and structure-activity relationships of piperidine and dehydropiperidine carboxylic acids as novel, potent dual PPARalpha/gamma agonists. |
Bristol-Myers Squibb R & D |
18272370 |
2 |
Design, synthesis, biological evaluation and docking studies of pterostilbene analogs inside PPARalpha. |
Usda-Ars |
17062777 |
32 |
Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling. |
Bristol-Myers Squibb |
18155554 |
87 |
Synthesis and structure-activity relationships of thiadiazole-derivatives as potent and orally active peroxisome proliferator-activated receptors alpha/delta dual agonists. |
Johnson & Johnson Pharmaceutical Research And Development |
17964792 |
31 |
Structure-activity studies on 1,3-dioxane-2-carboxylic acid derivatives, a novel class of subtype-selective peroxisome proliferator-activated receptor alpha (PPARalpha) agonists. |
Nippon Shinyaku |
18162399 |
37 |
SAR-oriented discovery of peroxisome proliferator-activated receptor pan agonist with a 4-adamantylphenyl group as a hydrophobic tail. |
University Of Tokyo |
18280733 |
27 |
Discovery of a novel class of 1,3-dioxane-2-carboxylic acid derivatives as subtype-selective peroxisome proliferator-activated receptor alpha (PPARalpha) agonists. |
Nippon Shinyaku |
18083521 |
4 |
Omega-(2-Naphthyloxy) amino alkanes as a novel class of anti-hyperglycemic and lipid lowering agents. |
Central Drug Research Institute |
18291645 |
108 |
Discovery of azetidinone acids as conformationally-constrained dual PPARalpha/gamma agonists. |
Bristol-Myers Squibb Research And Development |
18029176 |
66 |
Design and synthesis of indane-ureido-thioisobutyric acids: A novel class of PPARalpha agonists. |
Johnson & Johnson |
17560785 |
12 |
Design of a partial PPARdelta agonist. |
Novo Nordisk |
17010604 |
3 |
Structure-based de novo design, synthesis, and biological evaluation of the indole-based PPARgamma ligands (I). |
Fudan University |
17005393 |
35 |
Tetrahydroisoquinoline PPARgamma agonists: design of novel, highly selective non-TZD antihyperglycemic agents. |
Eli Lilly |
16821769 |
16 |
Design and synthesis of the first generation of dithiolane thiazolidinedione- and phenylacetic acid-based PPARgamma agonists. |
University Of Mississippi |
16220969 |
219 |
Designed multiple ligands. An emerging drug discovery paradigm. |
Organon Laboratories |
12951090 |
57 |
O-arylmandelic acids as highly selective human PPAR alpha/gamma agonists. |
Merck Research Laboratories |
10714503 |
18 |
Novel oximes having 5-benzyl-2,4-thiazolidinedione as antihyperglycemic agents: synthesis and structure-activity relationship. |
Sankyo |
22342624 |
2 |
Acetylenic acid analogues from the edible mushroom Chanterelle (Cantharellus cibarius) and their effects on the gene expression of peroxisome proliferator-activated receptor-gamma target genes. |
Korea University |
22341573 |
39 |
Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptorsa/¿ dual agonists. |
Universit£ |
22225641 |
13 |
Substituents at the naphthalene C3 position of (-)-Cercosporamide derivatives significantly affect the maximal efficacy as PPAR¿ partial agonists. |
Daiichi Sankyo |
22070604 |
150 |
Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor¿ (PPAR¿) modulators. |
Merck Research Laboratories |
22209730 |
73 |
A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR)¿ agonists: design and synthesis of benzylpyrazole acylsulfonamides. |
Takeda Pharmaceutical |
22197396 |
57 |
Novel (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: peroxisome proliferator-activated receptor¿ selective agonists with protein-tyrosine phosphatase 1B inhibition. |
Kyoto Pharmaceutical Industries |
22133631 |
76 |
Discovery of cyclic amine-substituted benzoic acids as PPARa agonists. |
Kyorin Pharmaceutical |
22051054 |
18 |
Synthesis, molecular modeling studies and biological evaluation of fluorine substituted analogs of GW 501516. |
University Of Oslo |
21873070 |
29 |
SAR studies of acidic dual¿-secretase/PPAR¿ modulators. |
Goethe-University Frankfurt |
21514830 |
39 |
Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: relationship between absolute configuration and subtype selectivity. |
The University Of Tokyo |
21450468 |
22 |
Revisiting glitazars: thiophene substituted oxazole containinga-ethoxy phenylpropanoic acid derivatives as highly potent PPARa/¿ dual agonists devoid of adverse effects in rodents. |
Zydus Research Centre |
20850970 |
27 |
Novel thiazolidinedione derivatives with anti-obesity effects: dual action as PTP1B inhibitors and PPAR-¿ activators. |
Inha University |
21557540 |
39 |
Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-¿. |
Pfizer |
21482446 |
55 |
Discovery of new nanomolar peroxisome proliferator-activated receptor κ activators via elaborate ligand-based modeling. |
Universiti Sains Malaysia |
19423341 |
6 |
Design, synthesis and insulin-sensitizing activity of indomethacin and diclofenac derivatives. |
Guiyang Medical College |
21530275 |
42 |
Structure-based design, synthesis, and nonalcoholic steatohepatitis (NASH)-preventive effect of phenylpropanoic acid peroxisome proliferator-activated receptor (PPAR)a-selective agonists. |
Okayama University |
21515063 |
60 |
Biological evaluation of novel benzisoxazole derivatives as PPARd agonists. |
Nippon Chemiphar |
21377875 |
19 |
Synthesis and pharmacological evaluation of novel benzoylazole-based PPARa/κ activators. |
Dainippon Sumitomo Pharma |
21094606 |
24 |
Discovery of isoindoline and tetrahydroisoquinoline derivatives as potent, selective PPARd agonists. |
Astrazeneca R&D Charnwood |
21130649 |
11 |
Development of a new class of benzoylpyrrole-based PPARa/¿ activators. |
Dainippon Sumitomo Pharma |
21112784 |
15 |
Synthesis of a novel human PPARd selective agonist and its stimulatory effect on oligodendrocyte differentiation. |
Nippon Chemiphar |
21215640 |
21 |
Effect of structurally constrained oxime-ether linker on PPAR subtype selectivity: Discovery of a novel and potent series of PPAR-pan agonists. |
Zydus Research Centre |
21074432 |
25 |
Selective peroxisome proliferator-activated receptord isosteric selenium agonists as potent anti-atherogenic agents in vivo. |
Seoul National University |
21030263 |
5 |
1,3-Diphenyl-1H-pyrazole derivatives as a new series of potent PPAR¿ partial agonists. |
Sookmyung Women'S University |
20656494 |
11 |
Characterization of new PPARgamma agonists: benzimidazole derivatives-importance of positions 5 and 6, and computational studies on the binding mode. |
Freie UniversitäT Berlin |
20638278 |
145 |
Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists. |
Phenex Pharmaceuticals |
20503989 |
29 |
Design, synthesis, and biological evaluation of a novel class of gamma-secretase modulators with PPARgamma activity. |
Zafes/Liff/Goethe University Frankfurt |
20471839 |
4 |
Synthesis and anti-inflammatory activity of new arylidene-thiazolidine-2,4-diones as PPARgamma ligands. |
Universidade Federal De Pernambuco |
20452212 |
26 |
Glycine amides as PPARalpha agonists. |
Bayer-Schering Pharma |
20356736 |
48 |
Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation. |
Bristol-Myers Squibb R & D |
20347594 |
7 |
Truxillic acid derivatives act as peroxisome proliferator-activated receptor gamma activators. |
Goethe-University Frankfurt |
20307981 |
16 |
Rational design of a pirinixic acid derivative that acts as subtype-selective PPARgamma modulator. |
Goethe-University Frankfurt |
20218621 |
131 |
Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453). |
Bristol-Myers Squibb |
19928766 |
425 |
Novel bisaryl substituted thiazoles and oxazoles as highly potent and selective peroxisome proliferator-activated receptor delta agonists. |
The Genomics Institute Of The Novartis Research Foundation |
19853439 |
21 |
Novel biphenylcarboxylic acid peroxisome proliferator-activated receptor (PPAR) delta selective antagonists. |
The University Of Tokyo |
20022492 |
29 |
Design and synthesis of novel bis-oximinoalkanoic acids as potent PPARalpha agonists. |
Zydus Research Centre |
20079636 |
78 |
Synthesis and biological activities of novel indole derivatives as potent and selective PPARgamma modulators. |
Glaxosmithkline |
19807106 |
11 |
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists. |
The University Of Sydney |
19775169 |
41 |
New 2-aryloxy-3-phenyl-propanoic acids as peroxisome proliferator-activated receptors alpha/gamma dual agonists with improved potency and reduced adverse effects on skeletal muscle function. |
Universit£ |
19556125 |
42 |
Discovery of a novel class of 2-mercaptohexanoic acid derivatives as highly active PPARalpha agonists. |
Goethe-University Frankfurt |
19719236 |
23 |
Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by nitroalkene fatty acids: importance of nitration position and degree of unsaturation. |
Wake Forest University |
19376700 |
21 |
4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARalpha/gamma agonists. Part. II: Synthesis and pharmacological evaluation of oxime and acidic head group structural variations. |
Umr Gicc |
19530681 |
79 |
Discovery of a peroxisome proliferator activated receptor gamma (PPARgamma) modulator with balanced PPARalpha activity for the treatment of type 2 diabetes and dyslipidemia. |
Merck Research Laboratories |
| 22 |
Solid-phase synthesis of hybrid thiazolidinedione-fatty acid PPARγ ligands |
TBA |
| 4 |
Non thiazolidinedione antihyperglycaemic agents. 2: α-Carbon substituted β-phenylpropanoic acids1 |
TBA |
| 9 |
Non thiazolidinedione antihyperglycaemic agents. 1: α-Heteroatom substituted β-phenylpropanoic acids |
TBA |
19507861 |
18 |
Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic acid (MK-0533): a novel selective peroxisome proliferator-activated receptor gamma modulator for the treatment of type 2 diabetes mellitus with a reduced potential to increase plasma a |
Merck Research Laboratories |
19349176 |
137 |
Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes. |
F. Hoffmann-La Roche |
19301897 |
63 |
Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists. |
National Health Research Institutes |
19275963 |
26 |
Selective, potent PPARgamma agonists with cyclopentenone core structure. |
Universidade De Vigo |
19201606 |
86 |
Design, synthesis and structure-activity relationships of azole acids as novel, potent dual PPAR alpha/gamma agonists. |
Bristol-Myers Squibb Research And Development |
18947994 |
102 |
The discovery of equipotent PPARalpha/gamma dual activators. |
Glaxosmithkline |
18835719 |
42 |
Synthesis, biological evaluation, and molecular modeling investigation of chiral 2-(4-chloro-phenoxy)-3-phenyl-propanoic acid derivatives with PPARalpha and PPARgamma agonist activity. |
Università |
18821746 |
10 |
Discovery of novel PPAR ligands by a virtual screening approach based on pharmacophore modeling, 3D shape, and electrostatic similarity screening. |
University Of Innsbruck |
18809325 |
13 |
Analogues of 2-phenyl-ethenesulfonic acid phenyl ester have dual functions of inhibiting expression of inducible nitric oxide synthase and activating peroxisome proliferator-activated receptor gamma. |
National Health Research Institutes |
18805005 |
8 |
Discovery of a highly orally bioavailable c-5-[6-(4-Methanesulfonyloxyphenyl)hexyl]-2-methyl-1,3-dioxane-r-2-carboxylic acid as a potent hypoglycemic and hypolipidemic agent. |
Zydus Research Centre |
18771917 |
68 |
Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARalpha/gamma dual agonists. |
Yuhan Research Institute |
18701276 |
97 |
Highly functionalized 7-azaindoles as selective PPAR gamma modulators. |
Merck Research Laboratories |
18665581 |
23 |
Sulindac derivatives that activate the peroxisome proliferator-activated receptor gamma but lack cyclooxygenase inhibition. |
Vanderbilt University Center For Structural Biology |
18662876 |
45 |
Improvement of the transactivation activity of phenylpropanoic acid-type peroxisome proliferator-activated receptor pan agonists: effect of introduction of fluorine at the linker part. |
The University Of Tokyo |
18625559 |
16 |
Design and synthesis of novel oxazole containing 1,3-dioxane-2-carboxylic acid derivatives as PPAR alpha/gamma dual agonists. |
Zydus Research Centre |
18477507 |
1 |
Effects of amide constituents from pepper on adipogenesis in 3T3-L1 cells. |
Kyoto Pharmaceutical University |
18329751 |
40 |
Synthesis and evaluation of a series of benzopyran derivatives as PPAR alpha/gamma agonists. |
Graduate School Of The Chinese Academy Of Sciences |
18321611 |
64 |
CoMFA analysis of dual/multiple PPAR activators. |
National Institute Of Pharmaceutical Education And Research |
16643023 |
2 |
Bioassay for the identification of natural product-based activators of peroxisome proliferator-activated receptor-gamma (PPARgamma): the marine sponge metabolite psammaplin A activates PPARgamma and induces apoptosis in human breast tumor cells. |
University Of Mississippi |
11975517 |
3 |
Two new furanoditerpenes from Saururus chinenesis and their effects on the activation of peroxisome proliferator-activated receptor gamma. |
Korea Research Institute Of Bioscience And Biotechnology |
18255290 |
28 |
4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARalpha/gamma agonists. Part I: synthesis and pharmacological evaluation. |
Spot-Ea3857 |
18060776 |
100 |
Design, synthesis and evaluation of trifluoromethane sulfonamide derivatives as new potent and selective peroxisome proliferator-activated receptor alpha agonists. |
Glaxosmithkline |
18044841 |
12 |
Chlorocyclinones A-D, chlorinated angucyclinones from Streptomyces sp. strongly antagonizing rosiglitazone-induced PPAR-gamma activation. |
Boehringer Ingelheim Pharma |
18029178 |
188 |
Design and synthesis of novel and potent amide linked PPARgamma/delta dual agonists. |
Eli Lilly |
18023179 |
58 |
Carboxylic acid based quinolines as liver X receptor modulators that have LXRbeta receptor binding selectivity. |
Wyeth Pharmaceuticals |
17624777 |
31 |
Synthesis and structure-activity relationship of novel indene N-oxide derivatives as potent peroxisome proliferator activated receptor gamma (PPARgamma) agonists. |
Korea Research Institute Of Chemical Technology |
17618115 |
1 |
Mycophenolic acid as a latent agonist of PPARgamma. |
Hokkaido University |
17601734 |
102 |
Indanylacetic acids as PPAR-delta activator insulin sensitizers. |
Bayer Research Center |
17574414 |
15 |
Design and synthesis of 6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid derivatives as PPARgamma activators. |
National Institute Of Pharmaceutical Education And Research |
17553681 |
50 |
Novel selective PPARdelta agonists: optimization of activity by modification of alkynylallylic moiety. |
Re&D Vufb |
17553678 |
97 |
Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor alpha agonists. |
Kowa |
17532641 |
57 |
Design, synthesis, and evaluation of potent, structurally novel peroxisome proliferator-activated receptor (PPAR) delta-selective agonists. |
University Of Tokyo |
17524643 |
14 |
Phenylpropanoic acid derivatives bearing a benzothiazole ring as PPARdelta-selective agonists. |
Nagoya City University |
17524639 |
73 |
Discovery of para-alkylthiophenoxyacetic acids as a novel series of potent and selective PPARdelta agonists. |
Johnson And Johnson Pharmaceutical Research And Development |
17512197 |
101 |
Synthesis and SAR of selective benzothiophene, benzofuran, and indole-based peroxisome proliferator-activated receptor delta agonists. |
Pfizer |
17507225 |
34 |
Design, synthesis, and structure-activity relationship of carbamate-tethered aryl propanoic acids as novel PPARalpha/gamma dual agonists. |
Seoul National University |
17498950 |
69 |
Discovery of highly potent and selective benzyloxybenzyl-based peroxisome proliferator-activator receptor (PPAR) delta agonists. |
Pfizer |
17379517 |
45 |
Design of potent PPARalpha agonists. |
Novo Nordisk |
17343371 |
27 |
Identification and synthesis of a novel selective partial PPARdelta agonist with full efficacy on lipid metabolism in vitro and in vivo. |
Novo Nordisk |
17292606 |
91 |
Discovery of tertiary aminoacids as dual PPARalpha/gamma agonists-I. |
Bristol-Myers Squibb Pharmaceutical Research Institute |
17129725 |
90 |
Design and synthesis of a novel class of dual PPARgamma/delta agonists. |
Eli Lilly |
17034149 |
22 |
Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists. |
National Health Research Institutes |
17005394 |
49 |
Synthesis and evaluation of aminomethyl dihydrocinnamates as a new class of PPAR ligands. |
Eli Lilly |
16979341 |
59 |
Pyridine-2-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents. |
Pfizer |
16973358 |
113 |
Pyridine-3-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents. |
Pfizer |
16970391 |
88 |
Design and synthesis of dual peroxisome proliferator-activated receptors gamma and delta agonists as novel euglycemic agents with a reduced weight gain profile. |
Eli Lilly |
16919947 |
30 |
Design and synthesis of novel N-sulfonyl-2-indole carboxamides as potent PPAR-gamma binding agents with potential application to the treatment of osteoporosis. |
Procter And Gamble Pharmaceuticals |
16854085 |
11 |
Indenone derivatives: a novel template for peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. |
Korea Research Institute Of Chemical Technology |
16797985 |
26 |
Studies towards the conception of new selective PPARbeta/delta ligands. |
Université |
16750626 |
51 |
3,4,5-Trisubstituted isoxazoles as novel PPARdelta agonists: Part 1. |
The Genomics Institute Of The Novartis Research Foundation |
16737814 |
112 |
Structure-based design of indole propionic acids as novel PPARalpha/gamma co-agonists. |
F. Hoffmann-La Roche |
16640330 |
5 |
Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities. |
National Health Research Institutes |
16546385 |
81 |
1,3,5-Trisubstituted aryls as highly selective PPARdelta agonists. |
The Genomics Institute Of The Novartis Research Foundation |
16529931 |
139 |
SAR studies: designing potent and selective LXR agonists. |
Merck Research Laboratories |
16451087 |
41 |
Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studies. |
National Health Research Institutes |
16384704 |
86 |
Design and synthesis of potent and subtype-selective PPARalpha agonists. |
Merck Research Laboratories |
16366601 |
82 |
Novel indole-based peroxisome proliferator-activated receptor agonists: design, SAR, structural biology, and biological activities. |
National Health Research Institutes |
16275080 |
174 |
Substituted indanylacetic acids as PPAR-alpha-gamma activators. |
Bayer Research Center |
16275077 |
27 |
Design and synthesis of substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor alpha/delta dual agonists. |
University Of Tokyo |
16153845 |
81 |
Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARgamma partial agonists. |
Merck Research Laboratories |
16137885 |
59 |
Synthesis of new carbo- and heterocyclic analogues of 8-HETE and evaluation of their activity towards the PPARs. |
Cnrs Umr 6052 |
16107159 |
106 |
Novel 2,3-dihydrobenzofuran-2-carboxylic acids: highly potent and subtype-selective PPARalpha agonists with potent hypolipidemic activity. |
Merck Research Laboratories |
16107150 |
39 |
Synthesis, biological evaluation, and molecular modeling investigation of new chiral fibrates with PPARalpha and PPARgamma agonist activity. |
Università |
15974597 |
96 |
Design and synthesis of alpha-aryloxyphenylacetic acid derivatives: a novel class of PPARalpha/gamma dual agonists with potent antihyperglycemic and lipid modulating activity. |
Merck Research Laboratories |
15950464 |
146 |
(2R)-2-methylchromane-2-carboxylic acids: discovery of selective PPARalpha agonists as hypolipidemic agents. |
Merck Research Laboratories |
15863293 |
30 |
Selective PPARgamma modulators with improved pharmacological profiles. |
Merck Research Laboratories |
15801817 |
32 |
Discovery of a novel series of peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes and dyslipidemia. |
Merck Research Laboratories |
15771468 |
19 |
Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activities. |
Bristol-Myers Squibb Pharmaceutical Research Institute |
15603954 |
37 |
Benzoyl 2-methyl indoles as selective PPARgamma modulators. |
Merck Research Laboratories |
15582409 |
46 |
2-Alkoxydihydrocinnamates as PPAR agonists. Activity modulation by the incorporation of phenoxy substituents. |
Eli Lilly |
15293980 |
47 |
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes. |
Glaxosmithkline |
15177462 |
38 |
Design, synthesis, and evaluation of a new class of noncyclic 1,3-dicarbonyl compounds as PPARalpha selective activators. |
Research Institute Of Tsinghua University |
15163205 |
94 |
(2R)-2-ethylchromane-2-carboxylic acids: discovery of novel PPARalpha/gamma dual agonists as antihyperglycemic and hypolipidemic agents. |
Merck Research Laboratories |
15115385 |
68 |
Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonists. |
Eli Lilly |
14695833 |
46 |
Benzoxazinones as PPARgamma agonists. 2. SAR of the amide substituent and in vivo results in a type 2 diabetes model. |
Johnson And Johnson Pharmaceutical Research And Development |
14613314 |
53 |
Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonist. |
Eli Lilly |
14592510 |
150 |
Design and synthesis of novel RXR-selective modulators with improved pharmacological profile. |
Ligand Pharmaceuticals |
14584939 |
32 |
Large dimeric ligands with favorable pharmacokinetic properties and peroxisome proliferator-activated receptor agonist activity in vitro and in vivo. |
Novo Nordisk |
14505666 |
99 |
Aryloxazolidinediones: identification of potent orally active PPAR dual alpha/gamma agonists. |
Merck Research Laboratories |
12951091 |
36 |
Design and synthesis of fluorinated RXR modulators. |
Eli Lilly |
12904063 |
69 |
Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor alpha subtype-selective activators. |
Kyorin Pharmaceutical |
12873517 |
90 |
5-aryl thiazolidine-2,4-diones: discovery of PPAR dual alpha/gamma agonists as antidiabetic agents. |
Merck Research Laboratories |
12801232 |
71 |
Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes. |
Ligand Pharmaceuticals |
12729668 |
106 |
5-Aryl thiazolidine-2,4-diones as selective PPARgamma agonists. |
Merck Research Laboratories |
12699745 |
49 |
Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity. |
Glaxosmithkline |
12672231 |
18 |
Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazar. |
Novo Nordisk |
12657263 |
46 |
Phenylacetic acid derivatives as hPPAR agonists. |
Merck Research Laboratories |
12617924 |
140 |
Amphipathic 3-phenyl-7-propylbenzisoxazoles; human pPaR gamma, delta and alpha agonists. |
Merck Research Laboratories |
12482434 |
52 |
Design and synthesis of novel PPARalpha/gamma/delta triple activators using a known PPARalpha/gamma dual activator as structural template. |
Novo Nordisk |
12443777 |
63 |
Synthesis and pharmacological evaluation of a new class of peroxisome proliferator-activated receptor modulators. |
Biovitrum |
11906293 |
7 |
Novel 5-substituted 2,4-thiazolidinedione and 2,4-oxazolidinedione derivatives as insulin sensitizers with antidiabetic activities. |
Takeda Chemical Industries |
11831892 |
46 |
Novel tricyclic-alpha-alkyloxyphenylpropionic acids: dual PPARalpha/gamma agonists with hypolipidemic and antidiabetic activity. |
Novo Nordisk |
11814790 |
8 |
Enantio-dependent binding and transactivation of optically active phenylpropanoic acid derivatives at human peroxisome proliferator-activated receptor alpha. |
Kyorin Pharmaceutical |
11738577 |
19 |
Design, synthesis and evaluation of substituted phenylpropanoic acid derivatives as peroxisome proliferator-activated receptor (PPAR) activators: novel human PPARalpha-selective activators. |
Kyorin Pharmaceutical |
11720854 |
48 |
Synthesis and biological activity of L-tyrosine-based PPARgamma agonists with reduced molecular weight. |
Glaxosmithkline |
11677135 |
21 |
Identification of a series of PPAR gamma/delta dual agonists via solid-phase parallel synthesis. |
Glaxosmithkline |
11527737 |
70 |
Identification of a series of oxadiazole-substituted alpha-isopropoxy phenylpropanoic acids with activity on PPARalpha, PPARgamma, and PPARdelta. |
Glaxosmithkline |
11405642 |
33 |
Design and synthesis of 2-methyl-2-[4-(2-[5-methyl-2-aryloxazol-4-yl]ethoxy)phenoxy]propionic acids: a new class of dual PPARalpha/gamma agonists. |
Eli Lilly |
11354382 |
42 |
Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis. |
Glaxosmithkline |
10691680 |
72 |
The PPARs: from orphan receptors to drug discovery. |
Glaxo Wellcome Research & Development |
10612594 |
32 |
Synthesis and biological activity of a novel series of indole-derived PPARgamma agonists. |
Glaxo Wellcome Research And Development |
10508427 |
42 |
A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activity. |
Glaxo Wellcome Research & Development |
10098657 |
2 |
(3-substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents. |
Kyorin Pharmaceutical |
9934490 |
4 |
Differential activity of rosiglitazone enantiomers at PPAR gamma. |
Glaxo Wellcome Research And Development |
29446942 |
98 |
Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR)?/?/? Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate. |
Inventiva |
29316397 |
47 |
Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 Agonists. |
Bristol-Myers Squibb |
28539218 |
25 |
Switching subtype-selectivity: Fragment replacement strategy affords novel class of peroxisome proliferator-activated receptor?/? (PPAR?/?) dual agonists. |
The University Of Tokyo |
28465099 |
26 |
Structure-activity relationships of rosiglitazone for peroxisome proliferator-activated receptor gamma transrepression. |
The University Of Tokyo |
28845983 |
81 |
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis. |
Goethe-University Frankfurt |
28799755 |
51 |
Polypharmacology of N |
Sahmyook University |
28485590 |
15 |
Structure-Activity Relationship of 2,4-Dichloro-N-(3,5-dichloro-4-(quinolin-3-yloxy)phenyl)benzenesulfonamide (INT131) Analogs for PPAR?-Targeted Antidiabetics. |
The Scripps Research Institute |
11160654 |
10 |
Pharmacological properties of the potent epileptogenic amino acid dysiherbaine, a novel glutamate receptor agonist isolated from the marine sponge Dysidea herbacea. |
Kitasato University |
10991998 |
32 |
Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition. |
Wake Forest University |
21671327 |
5 |
Triptolide directly inhibits dCTP pyrophosphatase. |
Yale University |
8474008 |
58 |
Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. |
Virginia Commonwealth University |
20373302 |
5 |
The identification of a novel natural activator of p300 histone acetyltranferase provides new insights into the modulation mechanism of this enzyme. |
Universitá |
19827080 |
10 |
A fragment-based approach to probing adenosine recognition sites by using dynamic combinatorial chemistry. |
University Of Cambridge |
19954435 |
116 |
Heme oxygenase inhibition by 2-oxy-substituted 1-azolyl-4-phenylbutanes: effect of variation of the azole moiety. X-ray crystal structure of human heme oxygenase-1 in complex with 4-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone. |
Queen'S University |
19843080 |
43 |
The design, synthesis and potential utility of fluorescence probes that target DFG-out conformation of p38alpha for high throughput screening binding assay. |
Pfizer |
8461029 |
21 |
Characterization of recombinant human serotonin 5HT1A receptors expressed in Chinese hamster ovary cells. [3H]spiperone discriminates between the G-protein-coupled and -uncoupled forms. |
University Of Canterbury |
8413837 |
45 |
[3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments. |
Boots Pharmaceuticals |
8394987 |
32 |
Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. |
Cnrs |
18089721 |
10 |
New inhibitors of ABCG2 identified by high-throughput screening. |
Saic-Frederick |